Corient Private Wealth LP Makes New $2.30 Million Investment in Nutrien Ltd. $NTR

Key Points

• Corient Private Wealth LP bought 146,785 Nutrien shares during the second quarter, representing a new investment valued at approximately $2.30 million. Institutional investors collectively own 63.1% of Nutrien.
• Nutrien shares recently traded at $80.32, up 3.4%, near the upper end of their 52-week range. The company reported quarterly revenue of $10.81 billion, though earnings of $2.61 per share fell short of analyst expectations.
• Nutrien declared a quarterly dividend of $0.55 per share, equivalent to an annualized $2.20 dividend and a 2.7% yield. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $81.58.

Corient Private Wealth LP purchased a new position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 146,785 shares of the company's stock, valued at approximately $2,303,000.

A number of other large investors also recently modified their holdings of NTR. Wellington Management Group LLP grew its position in Nutrien by 440.2% during the 4th quarter. Wellington Management Group LLP now owns 16,338,606 shares of the company's stock worth $1,008,713,000 after acquiring an additional 13,313,817 shares during the last quarter. First Eagle Investment Management LLC raised its position in Nutrien by 0.5% in the fourth quarter. First Eagle Investment Management LLC now owns 13,307,283 shares of the company's stock valued at $821,326,000 after purchasing an additional 70,068 shares during the last quarter. Deutsche Bank AG raised its position in Nutrien by 2.0% in the fourth quarter. Deutsche Bank AG now owns 9,798,196 shares of the company's stock valued at $604,745,000 after purchasing an additional 189,683 shares during the last quarter. TD Asset Management Inc boosted its stake in shares of Nutrien by 21.2% during the fourth quarter. TD Asset Management Inc now owns 8,928,534 shares of the company's stock valued at $551,821,000 after purchasing an additional 1,559,673 shares in the last quarter. Finally, Mackenzie Financial Corp boosted its stake in shares of Nutrien by 4.4% during the fourth quarter. Mackenzie Financial Corp now owns 7,219,733 shares of the company's stock valued at $450,310,000 after purchasing an additional 305,458 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors.

Nutrien Trading Up 3.4%

Shares of NTR stock opened at $80.32 on Thursday. Nutrien Ltd. has a 1-year low of $53.03 and a 1-year high of $85.36. The company has a current ratio of 1.39, a quick ratio of 0.86 and a debt-to-equity ratio of 0.36. The stock has a market cap of $38.33 billion, a price-to-earnings ratio of 16.26, a PEG ratio of 0.82 and a beta of 0.62. The stock has a 50-day moving average of $68.32 and a 200-day moving average of $70.70.

Nutrien (NYSE:NTR - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $2.61 EPS for the quarter, missing analysts' consensus estimates of $2.70 by ($0.09). Nutrien had a return on equity of 8.88% and a net margin of 8.44%.The company had revenue of $10.81 billion during the quarter, compared to analyst estimates of $10.44 billion. During the same period in the prior year, the firm earned $2.65 earnings per share. Nutrien's revenue was up 3.6% compared to the same quarter last year. On average, equities research analysts forecast that Nutrien Ltd. will post 4.71 earnings per share for the current year.

Nutrien Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 16th. Stockholders of record on Tuesday, September 29th will be given a $0.55 dividend. The ex-dividend date is Tuesday, September 29th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.7%. Nutrien's payout ratio is 44.53%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Canadian Imperial Bank of Commerce reaffirmed an "outperform" rating on shares of Nutrien in a research note on Monday, August 10th. Wall Street Zen downgraded shares of Nutrien from a "buy" rating to a "hold" rating in a research report on Saturday, May 16th. UBS Group reduced their target price on shares of Nutrien from $67.00 to $65.00 and set a "sell" rating on the stock in a report on Monday, May 11th. National Bank Financial decreased their price target on shares of Nutrien from $76.00 to $74.00 and set an "outperform" rating for the company in a research report on Monday, August 10th. Finally, JPMorgan Chase & Co. raised their price target on shares of Nutrien from $78.00 to $80.00 and gave the company an "overweight" rating in a research note on Monday, May 11th. Seventeen research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $81.58.

About Nutrien

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.